CVE-2021-23874
McAfee Total Protection (MTP) Improper Privilege Management
- Published10 Feb 2021
- Added to CISA KEV3 Nov 2021
- Remediation due17 Nov 2021
Description
Arbitrary Process Execution vulnerability in McAfee Total Protection (MTP) prior to 16.0.30 allows a local user to gain elevated privileges and execute arbitrary code bypassing MTP self-defense.
CVSS 3.1 breakdown
CVSS:3.1/AV:L/AC:L/PR:L/UI:R/S:C/C:H/I:H/A:HAffected products
Remediation
References
Related CVEs
Recent high-severity vulnerabilities sharing a weakness type.
Frequently asked
Is CVE-2021-23874 being actively exploited?
Yes. CVE-2021-23874 is listed in the CISA Known Exploited Vulnerabilities (KEV) catalog, added 3 Nov 2021.
How severe is CVE-2021-23874?
CVE-2021-23874 has a CVSS 3.1 base score of 8.2, rated high. EPSS estimates a 1.03% probability of exploitation.
Which products are affected by CVE-2021-23874?
Affected products include Mcafee Total Protection.
How do I fix CVE-2021-23874?
Upgrade affected software to a fixed version, for example Mcafee Total Protection 16.0.30 or later, then confirm no affected versions remain in your inventory.
How Secuno handles this
Secuno correlates vulnerabilities like CVE-2021-23874 against the real software inventory on every managed device, every day. Rather than a static severity, each match is scored in context: exploit availability, EPSS, the asset's exposure, and business criticality decide where it lands in the queue. Because it is on the CISA KEV list, Secuno flags any affected asset as top-priority automatically. If an affected version is present anywhere across your portfolio, it surfaces automatically with a prioritised remediation path.
Data from the NVD, CISA KEV catalog and FIRST EPSS. CVSS 3.1 base score shown where available.